Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04724941
Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study
Sponsor: University Hospital Schleswig-Holstein
View on ClinicalTrials.gov
Summary
The PASS-PD study is set out to screen individuals from the general population with an increased risk for the development of Parkinson's Disease (PD) and to investigate this highly enriched cohort longitudinally for five year. A special focus is placed on implementation of ethical standards for early risk disclosure in PD.
Key Details
Gender
All
Age Range
50 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2021-06-01
Completion Date
2027-12
Last Updated
2025-09-22
Healthy Volunteers
Yes
Conditions
Interventions
OTHER
No intervention
No intervention
Locations (1)
Department for Neurology, University of Kiel
Kiel, Germany